Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by PROtradingon Mar 16, 2016 9:22am
87 Views
Post# 24663881

RE:RE:Game over

RE:RE:Game overCorrect.  The bashing clowns here don't want intelligent discussions. 

When novices see noisemakers, put them on ignore.

Bottom line, VRX is a trader's stock right now.  Investors should hold tight. 

The short attack on this at these prices shouldn't last long.

MOJOJONO wrote: Well.. I don't think more debt than equity = bankrupt. It's about cashflow and maturities.

If the debt all comes due at the same time then yes... if it is spaced out over several years then they'd be fine in THAT specific regard as long as cashflow supports the interest payments and eventually they are able to refinance or pay off the next maturing debt instrument.


<< Previous
Bullboard Posts
Next >>